Brussels, 30/06/2009 (Agence Europe) - The Commission should read more carefully the argument pout forward by pharmaceutical company GlaxoSmithKline, which is seeking exemption from certain EU competition rules. That is the opinion of the Advocate General of the Court of Justice, Verica Trstenjak, in her opinion on Tuesday 30 June.
In 2001, the Commission took action against the company for charging its Spanish intermediaries differing prices depending on whether they sold their products...